Genentech
South San Francisco · 21 people tracked
Investment thesis
Genentech focuses on advancing groundbreaking research in neuroscience to address hundreds of neurological disorders affecting nearly 100 million Americans. The firm prioritizes development of medicines for both common and rare neurological conditions, combines scientific innovation with equitable healthcare access initiatives, engages underrepresented communities in research recruitment, and partners with stakeholders to ensure broader access to care as global aging increases neurological disorder prevalence.
Source: firm website, verified Aug 6, 2026.
Team · 21 people
from the firm's website
Frequently asked questions
- What sectors does Genentech focus on?
- Genentech focuses on Biotech.
- Where is Genentech located?
- Genentech is headquartered in South San Francisco, US.
Images
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.